★ Sign in to follow
JH

Julie Hill

GB·RNS (LSE)
Hikma Pharmaceuticals PLC
Insider activity · 24 months4 buys0 salesCumulative net flow
Total declarations
12
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 22 Sept 2026 for Hikma Pharmaceuticals PLC, €4,060.

Filing timeline

BuySale
Julie Hill

Insider track record

Disclosed buys
0
Disclosed sells
0
T+90 hit rate
60%
T+90 mean return
+1.3%

Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Julie Hill: trading record in brief

This profile gathers the share dealings of Julie Hill in Hikma Pharmaceuticals PLC. We count 12 filings; the first trade dates from 6 March 2024 and the latest from 21 September 2026.

Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The record was last updated on 22 September 2026 with a share grant (€4,060) in Hikma Pharmaceuticals PLC. Filings reach the RNS (LSE) feed a median of 2 days after the trade. The legal deadline for notifying a trade is three business days (UK MAR). Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to Julie Hill

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total
  • ▲
    Julie Hill
    PDMRExecutivesHikma Pharmaceuticals PLC
    3,481 GBP0RNS
    218 shares@ £15.97London Stock Exchange (XLON)ISIN GB00B0LCW083RNS:9784482-1
    Canonical exit: 20 Dec 2026 (T+90)
  • ▲
    Julie Hill
    PDMRExecutivesHikma Pharmaceuticals PLC
    2,509 GBP11RNS
    178 shares@ £14.0981.8% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:549f9a76-e199-4690-8f52-59ddfd93c657-2
    Canonical exit: 3 Aug 2026 (T+90)
  • ◆
    Julie Hill
    PDMRExecutivesHikma Pharmaceuticals PLC
    40,852 GBP14RNS
    11,309 shares@ £13.0928.8% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:20a6a8b1-a14c-4475-9249-b33a586e281e-0
  • ◆
    Julie Hill
    PDMRExecutivesHikma Pharmaceuticals PLC
    0RNS
    40,043 sharesOutside a trading venueISIN GB00B0LCW083RNS:8692df49-f37d-43c7-8ebe-66aeba9a2ed8-6
  • ▲
    Julie Hill
    PDMRExecutivesHikma Pharmaceuticals PLC
    1,874 GBP11RNS
    115 shares@ £16.301.9% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:5832371-3
    Canonical exit: 21 Dec 2025 (T+90)
  • ◆
    Julie Hill
    PDMRExecutivesHikma Pharmaceuticals PLC
    48,836 GBP16RNS
    8,276 shares@ £21.3852.2% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:5680033-8
  • ▲
    Julie Hill
    PDMRExecutivesHikma Pharmaceuticals PLC
    1,214 GBP11RNS
    60 shares@ £20.231.3% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:5647004-2
    Canonical exit: 4 Aug 2025 (T+90)
  • ◆
    Julie Hill
    PDMRExecutivesHikma Pharmaceuticals PLC
    0RNS
    30,080 sharesOutside a trading venueISIN GB00B0LCW083RNS:5613092-8
  • ▲
    Julie Hill
    PDMRExecutivesHikma Pharmaceuticals PLC
    780 GBP11RNS
    41 shares@ £19.031.8% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:5361694-3
    Canonical exit: 22 Dec 2024 (T+90)
  • ▲
    Julie Hill
    PDMRExecutivesHikma Pharmaceuticals PLC
    1,168 GBP11RNS
    60 shares@ £19.342.7% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:5176047-3
    Canonical exit: 1 Aug 2024 (T+90)
  • ◆
    Julie Hill
    PDMRExecutivesHikma Pharmaceuticals PLC
    0RNS
    40,429 sharesOutside a trading venueISIN GB00B0LCW083RNS:5139884-9
  • ◆
    Julie Hill
    PDMRExecutivesHikma Pharmaceuticals PLC
    42,211 GBP19RNS
    7,529 shares@ £19.275100.0% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:5096544-1

12 of 12 declarations

Related entities

No related entities found.